Peter Welford

Stock Analyst at Jefferies

(0)
# 4697
Out of 5,438 analysts
20
Total ratings
Success rate
Average return
7 Stocks
Name Action PT Current % Upside Ratings Updated
GSK GSK
Downgrades: Hold
n/a
n/a n/a 3 Nov 12, 2024
NVS Novartis
Downgrades: Hold
n/a
n/a n/a 2 Sep 3, 2024
AZN AstraZeneca
Downgrades: Hold
n/a
n/a n/a 4 Jan 3, 2024
GLPG Galapagos
Upgrades: Hold
49 48
31.5 49.84% 3 Jan 23, 2023
GMAB Genmab
Downgrades: Hold
n/a
n/a n/a 1 Sep 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
5 460% 1 May 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Feb 1, 2019